Clinical Trial Update: Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows [Phase 4]

View source ↗

Summary

Phase 4 trial update shows safety and efficacy data for bimatoprost 0.03% solution in treating thinning eyebrows due to hypotrichosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis

Drugs mentioned

• bimatoprost 0.03% solution (bimatoprost)

Snippet

Sponsor: ATS Clinical Research | Conditions: Hypotrichosis | Phase 4 | Status: COMPLETED